Insider · CIK 0001723729

Bartram Richard

Reports to the SEC for 2 companies · CARMEL, IN

sec.gov

Transactions

Companies

Filings

CIK

0001723729

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-02	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Chief Financial Officer	AAward	+70K sh	—	—	70,000
2026-02-02	MBXMBX Biosciences, Inc.A Award	Chief Financial Officer	AAward	+15K sh	—	—	15,000
2025-02-03	MBXMBX Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+95K sh	—	—	95,000
2024-09-12	MBXMBX Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+42.6K sh	—	—	42,578
2022-03-14	ESPREsperion Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+37K sh	—	—	82,751
2021-10-29	ESPREsperion Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+18.7K sh	—	—	43,852
2021-06-28	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+37.5K sh	—	—	37,500
2021-06-28	ESPREsperion Therapeutics, Inc. · Performance-based Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+26.4K sh	—	—	26,400
2021-01-28	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2021-01-28	ESPREsperion Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+5,000 sh	—	—	23,617
2020-01-02	ESPREsperion Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+7,525 sh	—	—	18,673
2020-01-02	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+33.9K sh	—	—	33,900
2019-04-03	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	+1,500 sh	$43.62	+$65.4K	11,092
2019-04-03	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	+6,500 sh	$42.71	+$278K	12,592
2018-11-28	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+12K sh	—	—	12,000
2018-01-02	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.9K sh	—	—	0
2018-01-02	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+38.5K sh	—	—	38,500
2018-01-02	ESPREsperion Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.9K sh	$3.70	+$66.2K	19,092

Recent filings

Accepted (ET)
Feb 34
Bartram Richard0001193125-26-035584
SEC(opens sec.gov)
Feb 54
Bartram Richard0000950170-25-014497
SEC(opens sec.gov)
Sep 134
Bartram Richard0000950170-24-106467
SEC(opens sec.gov)
Mar 164
Bartram Richard0001628280-22-006408
SEC(opens sec.gov)
Nov 14
Bartram Richard0001628280-21-021008
SEC(opens sec.gov)
Jun 304
Bartram Richard0001628280-21-013223
SEC(opens sec.gov)
Jan 294
Bartram Richard0001628280-21-001178
SEC(opens sec.gov)
Jan 34
Bartram Richard0001179110-20-000170
SEC(opens sec.gov)
Apr 54
Bartram Richard0001179110-19-004803
SEC(opens sec.gov)
Nov 304
Bartram Richard0001179110-18-013334
SEC(opens sec.gov)
Jan 34
Bartram Richard0001179110-18-000394
SEC(opens sec.gov)

Companies

Address

C/O MBX BIOSCIENCES, INC. 11711 N. MERIDIAN STREET, SUITE 300

CARMEL, IN, 46032